, 1992). central nervous system (CNS). The development of oli-
Basic helix-loop-helix (bHLH) proteins are a family of godendrocytes is of considerable importance to an untranscriptional regulators that play a key role in cellderstanding of both neural development and the pathotype determination in a variety of tissues and organisms genesis of demyelinating diseases, such as multiple (reviewed by Garrell and Campuzano, 1991) . In the nersclerosis. Oligodendrocytes differentiate from bipolar, vous system, a large number of bHLH factors have been migratory precursor cells that arise from specific zones identified and studied genetically (reviewed by Kageof neuroepithelium and then disperse throughout develyama and Nakanishi, 1997; Lee, 1997). These factors oping gray matter (reviewed by Miller, 1996) . A great include vertebrate homologs of Drosophila proneural deal is known about the control of proliferation, survival, genes, such as Mash1, the Neurogenins, and NeuroD and differentiation of oligodendrocyte precursors (re- CNS. These genes are also expressed in the restricted Figure 2E ). Oligo1 genes were obtained using murine probes generated by expression declines to undetectable levels by E10.5 and PCR amplification of mouse genomic DNA with primers reappears in the same narrow zone as Oligo2 at E12.0 based on the human sequences. These data suggested ( Figure 2G ). Thus, both genes appear to have early and that Oligo1 and Oligo2 might be expressed in oligodenlate phases of expression within the ventral spinal cord. drocyte-generative zones of the spinal cord (see below). Double-labeling experiments confirmed that these two To obtain the entire coding sequences of Oligo1 and genes are expressed in the same zone of the neuroepiOligo2, we took advantage of the fact that the coding thelium at E12.0 ( Figures 3A and 3D ). sequences of many bHLH factors are contained within
The site of expression of these genes was highly remia single exon (e.g., see Guillemot et al., 1993; Fode et niscent of the region from which oligodendrocyte preal., 1998; Ma et al., 1998), and isolated and sequenced cursors have been reported to emerge in the spinal cord murine genomic clones encoding these genes. The de- (Pringle and Richardson, 1993) . We therefore compared duced amino acid sequences of Oligo1 and Oligo2 are the expression of Oligo2 and Oligo1 to that of several shown in Figure 1A . The two sequences are virtually other oligodendrocyte precursor markers. A comparison identical in the bHLH domain, except for the loop region, to PDGFR␣ indicated that the genes were indeed exwhich is significantly divergent (78% overall amino acid pressed in an overlapping if not identical domain of identity in the bHLH domain; Figure 1B) . Outside of the the neuroepithelium, except that the bHLH factors were bHLH region, however, the two sequences are highly expressed earlier than was the growth factor receptor. divergent ( Figure 1A ). Both sequences contain strings
Oligo2 is expressed about 1-1.5 days before PDGFR␣ of repeated amino acids outside of their bHLH domains, mRN is detectable (Figures 2A and 2L Taken together, these data suggest that Oligo2 and of these two mRNAs; Oligo1 signal was strong after an overnight development, while that for PDGFR␣ typically Oligo1 are specifically expressed by progenitors of oligodendrocyte precursors in the spinal cord in a sequentook 2 days to develop. Alternatively, a subset of migratory cells may express Oligo1 but not PDGFR␣.
tial and overlapping manner (see also Figure 3G , arrows). Oligo genes are expressed in oligodendrocyte-generative zones of the neuroepithelium and in oligodendrooverlap of Oligo gene expression with that of PDGFR␣ and Sox10 in both the spinal cord and in presumptive cyte precursors in other regions of the CNS. However, low levels of Oligo2 gene expression were also detected migrating oligodendrocyte precursors makes it highly unlikely that these bHLH genes are expressed in nonoliin the E13.5 and E14.5 retina, and both genes were expressed in the olfactory epithelium from E11.5 onward godendrocyte lineage cells coincidentally located in the same region of the ventricular zone as that from which (data not shown). These data suggest that while the expression of both Oligo genes marks sites of oligodenoligodendrocytes arise. This conclusion is supported by in situ hybridization experiments in dissociated primary drocyte precursor formation in the spinal cord and brain, these genes may also be expressed in developing pecultures of P5 optic nerve, which revealed Oligo1 and Oligo2 expression in elongated, bipolar cells with the ripheral sensory organs, where oligodendrocytes are not produced. At no time did we detect expression of characteristic morphology of oligodendrocyte precursors (also known as O-2A cells (Raff, 1989) as was Oligo2 virus alone ( Figures 6E and 6F) , indicating 8H, arrows). Although in some cases it appeared that some MF-20 ϩ myocytes coexpressed Sox10, it was diffithat the lack of effect of Oligo1 on its own was not due to an inhibitory effect on Sox10 expression. cult to unambiguously discriminate this from labeling in overlying, closely associated Sox10 ϩ cells, which are These data suggest that ectopic expression of Oligo2 in mesodermal lineage cells can induce Sox10, another likely to be myoblasts (Figure 8G , arrowheads; for technical reasons, it was not possible to perform in situ early transcription factor marker for oligodendrocyte precursors, but is insufficient to promote expression of hybridization for Sox10 mRNA with antibody staining for Pax7). Taken together, these observations suggest that later markers. Several pieces of evidence argue that it is unlikely that the ectopic expression of Sox10 simply ectopic expression of Oligo2 induces ectopic expression of Sox10 in myoblasts but that this expression is reflects proliferative expansion of neural crest-derived Sox10 ϩ Schwann cell precursors associated with pelargely extinguished upon differentiation of these cells to myocytes. The lack of ectopic Sox10 expression in ripheral nerves that course through the muscle ( Figures  6B and 6H, arrowheads) rather than induction in mesoother tissues expressing ectopic Oligo2, such as skin (Figure 6, arrows) , may reflect the fact that these are dermal cells. First, the cells expressing ectopic Sox10 in Oligo2-infected limbs ( Figures 7C and 7E, (Figures 8A-8D) 1996) or a more direct effect on Oligo gene expression.
been investigated in detail. Here, we show that Sox10 is abundantly expressed in the spinal cord at sites of Whatever the case, the fact that Shh is required for the sequential differentiation of both the neuronal and glial oligodendrocyte production and is induced at about the same time as Oligo2 and before both Oligo1 and lineages indicates that it is unlikely to explain the timing of oligodendrocyte production. Identification of the fac-PDGFR␣. Expression of Sox10 also persists in migratory oligodendrocyte precursors that express the other tors controlling the temporal onset of Oligo gene expression may help to shed light on this issue. genes. A dominant mutation in murine Sox10, called Dom, produces pigmentation defects and agangliogenExpression of Oligo2 appears restricted to the ventral spinal cord from the earliest stages we have examined esis of the bowel in heterozygotes (Southard-Smith et al., 1998), reflecting its early expression in neural crest (E9.5) but is initially expressed in a much broader zone than it is at later stages (E11.5). A similar narrowing of cells. The embryonic lethality obtained in Dom/Dom homozygotes precludes an assessment of its role in mythe zone of Oligo1 expression is seen as well, although this gene is expressed at much lower levels than Oligo2 elination, which occurs postnatally. That Sox10 is functionally important for oligodendrocyte development, is at such early stages. The significance of this early expression of Oligo genes, particularly that of Oligo2, is however, is suggested by the recent discovery of a human mutation in the gene that is associated with a CNS not clear. Although it occurs around the time when motor neurons are being generated, we did not observe any dysmyelinating disease (Inoue et al., 1999) . The fact that ectopically expressed Oligo2 is able to promote ectopic evidence of ectopic neuronal marker expression in either the spinal cord or the paraxial mesoderm of embryos expression of Sox10 in vivo therefore provides evidence of a functional role for Oligo2 in oligodendrocyte lineage ectopically expressing Oligo2 (data not shown). One possibility is that the early phase of Oligo2 expression determination. The inability of Oligo1 to induce ectopic Sox10 exprescontrols the timing of motor neuron generation by temporarily inhibiting such differentiation in the zone where sion is correlated with the fact that it is normally expressed after Sox10 and Oligo2. The sequential expresit is expressed. Alternatively, Oligo2 may play a positive acting role in the differentiation of motor neurons that sion of structurally related bHLH transcription factors is a characteristic feature of many differentiating lineages has thus far escaped detection in our functional assays.
(Jan and Jan, 1993); for example, muscle precursors sequentially express first MyoD (or Myf5) and then MyoEctopic Expression of Oligo Genes Promotes Ectopic Expression of Sox10 genin (Molkentin and Olson, 1996), while precursors of peripheral sensory neurons first express one of the NeuSox10 has been shown to be expressed in glial lineages in both the CNS and PNS (Kuhlbrodt et al., 1998 ), but rogenins, followed by one or more members of the NeuroD subfamily (Anderson, 1999). Such sequential exthe precise temporal relationship of its expression to that of other oligodendrocyte markers has not previously pression of bHLH genes is thought to underly the linked 
